Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

A guide to facilitate the early treatment of patients with idiopathic demyelinating disease (multiple sclerosis and neuromyelitis optica).
Arzerra receives approval in Japan
Opposite Roles of NMDA Receptors in Relapsing and Primary Progressive Multiple Sclerosis.
CHMP assessment report for Sovrima (International nonproprietary name: idebenone)
Lymphomatoid papulosis type D in a fingolimod-treated multiple sclerosis patient.
First NW patient to receive OHSU/VAMC-invented MS drug
Ceramide Synthase 6 Plays a Critical Role in the Development of Experimental Autoimmune Encephalomyelitis.
Glossopharyngeal neuralgia secondary to vascular compression in a patient with multiple sclerosis: a case report.
Visual Functional and Histopathological Correlation in Experimental Autoimmune Optic Neuritis.
Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) Patients (TERI-PRO)
Associations of CD6, TNFRSF1A, and IRF8 polymorphisms with risk of inflammatory demyelinating diseases.
New data show positive results from Phase 4 study of Avonex Pen for treatment of RRMS patients
[A comparison analysis of the use of intravenous β-interferon-1a 30 mcg and subcutaneous β-interferon-1a 44 mcg in routine clinical practice of treatment in patients with multiple sclerosis].
RebiSmart™ (version 1.5) device for multiple sclerosis treatment delivery and adherence.
Embryonic stem cell lines derived from human blastocysts.
Super-resolution imaging of aquaporin-4 orthogonal arrays of particles in cell membranes.
Multiple Sclerosis: Vitamin D and calcium as environmental determinants of prevalence (A Viewpoint)
Safety, Tolerability and Efficacy of Monthly Long-acting IM Injection of 80 mg GA Depot in Subjects With RRMS
MHC class I-restricted myelin epitopes are cross-presented by Tip-DCs that promote determinant spreading to CD8(+) T cells.
Improvement of internuclear ophthalmoparesis in multiple sclerosis with dalfampridine.
Reduced serum orexin-A levels in autoimmune encephalitis and neuromyelitis optica patients.
The immune modulator FTY720 targets sphingosine 1-phosphate receptors.
Multiple sclerosis susceptibility genes: associations with relapse severity and recovery.
Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies.
Neuromyelitis optica spectrum disorder: 2-deoxy-2-[(18)f]fluoro-d-glucose positron emission tomography findings.

Pages